PMC:7033706 / 7332-7988
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
199 | 321-329 | Species | denotes | SARS-CoV | Tax:694009 |
200 | 402-406 | Species | denotes | CoVs | Tax:11118 |
201 | 423-426 | Species | denotes | CoV | Tax:11118 |
202 | 443-446 | Species | denotes | CoV | Tax:11118 |
203 | 507-516 | Species | denotes | 2019-nCoV | Tax:2697049 |
204 | 192-200 | Species | denotes | SARS-CoV | Tax:694009 |
205 | 104-123 | Disease | denotes | 2019-nCoV infection | MESH:C000657245 |
206 | 281-300 | Disease | denotes | 2019-nCoV infection | MESH:C000657245 |
207 | 636-655 | Disease | denotes | 2019-nCoV infection | MESH:C000657245 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T34 | 104-123 | Disease | denotes | 2019-nCoV infection | http://purl.obolibrary.org/obo/MONDO_0100096 |
T35 | 114-123 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T36 | 192-200 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T37 | 281-300 | Disease | denotes | 2019-nCoV infection | http://purl.obolibrary.org/obo/MONDO_0100096 |
T38 | 291-300 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T39 | 321-329 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T40 | 636-655 | Disease | denotes | 2019-nCoV infection | http://purl.obolibrary.org/obo/MONDO_0100096 |
T41 | 646-655 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T95 | 264-272 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T96 | 395-398 | http://purl.obolibrary.org/obo/NCBITaxon_9397 | denotes | bat |
T97 | 408-419 | http://purl.obolibrary.org/obo/NCBITaxon_9397 | denotes | such as bat |
T98 | 436-439 | http://purl.obolibrary.org/obo/NCBITaxon_9397 | denotes | bat |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T52 | 399-401 | Chemical | denotes | SL | http://purl.obolibrary.org/obo/CHEBI_74815 |
T53 | 420-422 | Chemical | denotes | SL | http://purl.obolibrary.org/obo/CHEBI_74815 |
T54 | 440-442 | Chemical | denotes | SL | http://purl.obolibrary.org/obo/CHEBI_74815 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T40 | 0-124 | Sentence | denotes | It may take several months or even years for researching and developing neutralizing antibodies against 2019-nCoV infection. |
T41 | 125-301 | Sentence | denotes | One of the rapid approaches is to evaluate the currently available SARS-CoV neutralizing antibodies with cross-neutralizing and protection activity against 2019-nCoV infection. |
T42 | 302-517 | Sentence | denotes | We have shown that SARS-CoV S-RBD-specific neutralizing mAbs and sera could cross-neutralize bat-SL-CoVs, such as bat-SL-CoV-W1V1 and bat-SL-CoV-SHC014 [13], suggesting that they may also cross-neutralize 2019-nCoV. |
T43 | 518-656 | Sentence | denotes | Once identified, these cross-neutralizing antibodies can be promptly developed for urgent prevention and treatment of 2019-nCoV infection. |